Abstract
Due to increased occurrence of infections and food spoilage caused by yeast, there is an unmet need for new antifungal agents. The arginine-β-(2,5,7-tri-tert-butylindol-3-yl) alanine-arginine (R-Tbt-R) motif was previously proved useful in the design of an antifungal tripeptide. Here, an array of peptidomimetics based on this motif was investigated for antifungal and hemolytic activity. The five most promising modified tetrapeptide analogues ( 6: and 9-12: contain an additional C-terminal hydrophobic residue, and these were found to exhibit antifungal activity against Saccharomyces cerevisiae (MIC 6 and 12 μg mL(-1)) and Zygosaccharomyces bailii (MIC 6-25 μg mL(-1)). Four compounds ( 6: and 9-11: , had limited hemolytic activity (<10% hemolysis at 8 × MIC). Determination of their killing kinetics revealed that compound 9: displayed fungicidal effect. Testing against cells from an S. cerevisiae deletion mutant library indicated that interaction with yeast-specific fungal sphingolipids, most likely constitutes a crucial step in the mode of action. Interestingly, a lack of activity of peptidomimetics 6: and 9-11: towards Candida spp. was shown to be due to degradation or sequestering by the yeast. Due to their ultrashort nature, a...Continue Reading
References
May 1, 1991·Journal of Bacteriology·J L Patton, R L Lester
Jan 1, 1983·Antimicrobial Agents and Chemotherapy·A R Waldorf, A Polak
Nov 1, 1994·The British Journal of Ophthalmology·A GrinbaumC S Block
Nov 1, 1996·Journal of Bacteriology·G B WellsR L Lester
Mar 1, 1997·Current Genetics·M U JorgensenM C Kielland-Brandt
Oct 6, 1998·Annual Review of Biochemistry·R C Dickson
Aug 2, 2000·Proceedings of the National Academy of Sciences of the United States of America·R E Hancock, M G Scott
Aug 10, 2000·The Journal of Antimicrobial Chemotherapy·A VermesJ Dankert
Mar 7, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·D W BatesR Platt
Jul 26, 2002·Nature·Guri GiaeverMark Johnston
May 27, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Stanley C Deresinski, David A Stevens
Dec 19, 1962·Biochemical and Biophysical Research Communications·S C KINSKYH B ROGERS
Mar 19, 2004·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·A M TortoranoUNKNOWN ECMM Working Group on Candidaemia
Sep 26, 2006·Biochimica Et Biophysica Acta·L Ashley Cowart, Lina M Obeid
Jan 11, 2007·Journal of the American Chemical Society·Margaret A SchmittSamuel H Gellman
Feb 3, 2007·Current Medicinal Chemistry·B E HaugJ S M Svendsen
Jan 4, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Zeina A Kanafani, John R Perfect
Jan 15, 2008·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·UNKNOWN Subcommittee on Antifungal Susceptibility Testing (AFST) of the ESCMID European Committee for Antimicrobial Susceptibility T
Jul 14, 2010·Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology·Maristela B PortelaRosangela M A Soares
Jul 8, 2011·Journal of Medicinal Chemistry·Johan IsakssonWenche Stensen
Jul 18, 2012·Peptides·Yanmei LiZhijian Su
Jul 3, 2013·Fungal Biology·Jose C ThekkiniathMichael J San Francisco
Jul 17, 2013·International Journal of Food Microbiology·Malcolm StratfordDavid B Archer
Jul 23, 2013·PloS One·Rasmus BojsenBirgitte Regenberg
Citations
Aug 10, 2016·Future Medicinal Chemistry·Tecla CiociolaLuciano Polonelli
Sep 1, 2016·Molecular Pharmaceutics·Wenche StensenJohan Svenson
Feb 28, 2017·ACS Infectious Diseases·Chandradhish GhoshJayanta Haldar
May 31, 2018·Journal of Peptide Science : an Official Publication of the European Peptide Society·Christophe LabrièreJohan Svenson
Aug 10, 2019·Frontiers in Microbiology·Olena P IshchukJure Piškur